Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Sanofi strikes back in takeover battle for big Czech drug company
- PRAGUE AFP — Czech-based generic drugs giant Zentiva was at the heart of a takeover tussle Wednesday after French group Sanofi-Aventis struck back with an offer countering a bid by local financial concern PPF. PPF, holding a 19.2 percent stake in Zentiva, which has substantial markets in Slovakia, Romania...
- Research articles 2008-06-18
- Czech pharma giant buys Turkish peer
- PRAGUE AFP — The Czech Republic's biggest pharmaceutical company, Zentiva, said Monday that it had agreed to buy 75 percent of Turkey's biggest drug company Eczacibasi Generic Pharmaceuticals for 460 million euros (606.7 million dollars). The Czech company, which already has plants in Slovakia and Romania, added that it...
- Research articles 2007-03-05
- Why Can't Sanofi Get That Zentiva Deal Done?
- The M&A chess match going on between Sanofi-Aventis and Zentiva, a Czech Republic-based generic drug maker, is fascinating because it seems that the tiny Czech company is the one in a position of strength. Sanofi's bid was rejected by Zentiva on Wednesday. At first glance, it appears...
- Blog posts 2008-09-05
Additional Resources
- Research and Markets: Zentiva IMS Company Profile
- DUBLIN -- Research and Markets ( http://www.researchandmarkets.com/research/45ebcf/zentiva_ims_compan ) has announced the addition of the " Zentiva IMS Company Profile " company ...
- Articles 2009-04-23
- French pharma major sanofi-aventis is now expected to complete its 1.8bn [euro] acquisition of Czech generics producer Zentiva
- French pharma major sanofi-aventis is now expected to complete its 1.8bn [euro] acquisition of Czech generics producer Zentiva following the withdrawal of its opposition by the company's second largest shareholder, the Czech financial group PPF...
- Articles 2009-02-23
- Zentiva NV, the Czech drugmaker being acquired by Sanofi-Aventis SA, said its board unanimously recommended that shareholders accept the French company's offer and tender their stock
- Sanofi's all-cash bid of 1,150 Czech koruna ($66.21) a share is in the best interest of investors, the Prague-based company said in a Regulatory News Service statement. The deal values Zentiva at about $2.6 billion. Bel Viport Trading Ltd. raised its stake in Zentiva to 10%, according to a Dutch...
- Articles 2008-10-06
- Sanofi-Aventis SA, France's biggest drugmaker, received permission to extend its bid for Czech generic-drug maker Zentiva NV to give Sanofi more time to obtain regulatory approval
- Zentiva shareholders will be able to sell to Paris-based Sanofi until Nov. 28, instead of the original deadline of Sept. 19, the Czech central bank said last week. Zentiva Chief Executive Officer Jiri Michal has urged investors not to sell to the French drugmaker, saying its 30 billion-koruna ($1.8 billion)...
- Articles 2008-09-22
- Dutch headquartered pharma concern Zentiva, which operates in Central and Eastern Europe, has rejected an unsolicited takeover bid by French pharma major sanofi-aventis
- Dutch headquartered pharma concern Zentiva, which operates in Central and Eastern Europe, has rejected an unsolicited takeover bid by French pharma major sanofi-aventis. The offer of CZK10S0/share, making Zentiva worth $2.69bn, is said to undervalue the company, and follows an even lower offer by PPF. Sanofi-aventis already owns just under...
- Articles 2008-08-11
- Zentiva NV rejected as too low French drugmaker Sanofi-Aventis SA's $2 billion offer for the shares of the Czech generic drugmaker that it doesn't already own
- The bid, made the week prior, doesn't value Zentiva's improving operations or the potential of its Eastern European markets, the company said last week. Sanofi already owns a 24.9% stake and published its 1,050 koruna-a-share bid on July 11. The offer values Zentiva at 40 billion koruna ($2.7 billion), Paris-based...
- Articles 2008-07-21
- Sanofi starts takeover bid for Zentiva
- Sanofi Starts Takeover Bid for Zentiva. Sanofi-Aventis SA, France's biggest drugmaker, made its $2.02 billion offer for the remainder of Zentiva NV official last week, trumping PPF Group NV's bid for the Czech drugmaker. Sanofi already owns a 24.9% stake and published its 1,050 koruna-a-share bid Friday in Hospodarske Noviny....
- Articles 2008-07-14
- Sanofi-Aventis bids 1.65 billion euros for control of Zentiva
- PRAGUE AFP — French pharmaceutical group Sanofi-Aventis launched a bid worth 1.655 billion euros (2.6 billion dollars) for the 74.12 percent of Czech company Zentiva it does not already own on Friday. But the Zentiva board immediately urged shareholders to wait before taking any action. The...
- Articles 2008-07-11
- Sanofi plans counterbid for Zentiva
- Sanofi Plans Counterbid for Zentiva. French drugmaker Sanofi-Aventis SA plans to make a 40.04 billion crown ($2.6 billion) offer for Czech drugmaker Zentiva, trumping a bid from financial group PPF. The move would take Sanofi deeper into the field of generic drug production, an area which has traditionally been shunned...
- Articles 2008-06-23
- Sanofi strikes back in takeover battle for big Czech drug company
- PRAGUE AFP — Czech-based generic drugs giant Zentiva was at the heart of a takeover tussle Wednesday after French group Sanofi-Aventis struck back with an offer countering a bid by local financial concern PPF. PPF, holding a 19.2 percent stake in Zentiva, which has substantial markets in Slovakia,...
- Articles 2008-06-18
- Czech Republic Pharmaceuticals & Healthcare Report Q1 2008 Available Now
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c85962) has announced the addition of "Czech Republic Pharmaceuticals & Healthcare Report Q1 2008" to their offering. The Czech Republic Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on the Czech Republics pharmaceuticals and healthcare industry. The drug...
- Articles 2008-03-14
- Research and Markets: Major Regional Producers of Pharma from Central and Eastern Europe, Yet To Fall into the Hands of Larger Rivals, Include Krka, Sanitas and Zentiva
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c81374) has announced the addition of Business Strategies of Pharma Makers from Central and Eastern Europe 2007 - Acquisition Prospects and Development Forecasts to their offering. The report Business strategies of pharma makers from Central and Eastern Europe 2007 from PMR profiles...
- Articles 2008-01-31
- Major Regional Producers of Pharma from Central and Eastern Europe, Yet To Fall into the Hands of Larger Rivals, Include Krka, Sanitas and Zentiva.
- M2 PRESSWIRE-31 January 2008-Research and Markets: Major Regional Producers of Pharma from Central and Eastern Europe, Yet To Fall into the Hands of Larger Rivals, Include Krka, Sanitas and ZentivaC1994-2008 M2 COMMUNICATIONS LTD RDATE:01022008 Dublin - Research and Markets...
- Articles 2008-01-31
- Generics Companies Eye European M&A Targets
- Ratiopharm, Stada and Actavis identified as likely to make further strategic acquisitions, says URCH report LONDON -- Key European generics companies are poised to make further acquisitions as they fight to increase market share and defend profit margins, says a new report from URCH Publishing Ltd. ...
- Articles 2007-10-23
- Research and Markets: New Report Profiles Leading Central European Pharma Company; Zentiva
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c62615) has announced the addition of Zentiva Company Profile to their offering. IMS Health's Company Profiles give you the authoritative insight into a company at a strategic and local level. Each individual IMS Company Profile analyzes the critical components that...
- Articles 2007-07-13
- Study the Zentiva Generics Company Intelligence Report today.
- M2 PRESSWIRE-15 June 2007-Research and Markets: Study the Zentiva Generics Company Intelligence Report todayC1994-2007 M2 COMMUNICATIONS LTD RDATE:19062007 Dublin - Research and Markets (http://www.researchandmarkets.com/reports/c59843) has announced the addition of "Zentiva Generics Company Intelligence Report" to their offering ...
- Articles 2007-06-15
- Research and Markets: Study the Zentiva Generics Company Intelligence Report Today
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c28710) has announced the addition of "Zentiva Generics Company Intelligence Report" to their offering. The generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight...
- Articles 2007-06-15
- << Previous
- page 1 of 1
- Next >>
